These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18781955)

  • 1. Erythropoietin in cancer: an update.
    Tóvári J; Pirker R; Tímár J; Ostoros G; Kovács G; Döme B
    Curr Mol Med; 2008 Sep; 8(6):481-91. PubMed ID: 18781955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
    Liu W; Varier KM; Sample KM; Zacksenhaus E; Gajendran B; Ben-David Y
    Adv Exp Med Biol; 2020; 1223():17-30. PubMed ID: 32030683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
    Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
    Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin in tumor angiogenesis.
    Annese T; Tamma R; Ruggieri S; Ribatti D
    Exp Cell Res; 2019 Jan; 374(2):266-273. PubMed ID: 30576679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and co.: intrinsic structure and functional disorder.
    Uversky VN; Redwan EM
    Mol Biosyst; 2016 Dec; 13(1):56-72. PubMed ID: 27833947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
    Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
    Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modulation of the erythropoietic and tissue-protective effects of erythropoietin: time to reach the full therapeutic potential of erythropoietin.
    Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG
    Biochim Biophys Acta; 2007 Sep; 1776(1):1-9. PubMed ID: 17683868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
    Hedley BD; Chu JE; Ormond DG; Beausoleil MS; Boasie A; Allan AL; Xenocostas A
    Clin Cancer Res; 2011 Oct; 17(19):6151-62. PubMed ID: 21856770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F; Lee A
    Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain and cancer: the protective role of erythropoietin.
    Buemi M; Caccamo C; Nostro L; Cavallaro E; Floccari F; Grasso G
    Med Res Rev; 2005 Mar; 25(2):245-59. PubMed ID: 15389732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
    Kumar SM; Yu H; Fong D; Acs G; Xu X
    Melanoma Res; 2006 Aug; 16(4):275-83. PubMed ID: 16845323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of expression and function of erythropoietin receptors in the kidney.
    Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG
    Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis.
    Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M
    Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
    Tanaka T; Nangaku M
    Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.